These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31961646)

  • 1. Test-Retest Repeatability of [
    García-Varela L; Vállez García D; Rodríguez-Pérez M; van Waarde A; Sijbesma JWA; Schildt A; Kwizera C; Aguiar P; Sobrino T; Dierckx RAJO; Elsinga PH; Luurtsema G
    ACS Chem Neurosci; 2020 Feb; 11(4):648-658. PubMed ID: 31961646
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    García-Varela L; Rodríguez-Pérez M; Custodia A; Moraga-Amaro R; Colabufo NA; Aguiar P; Sobrino T; Dierckx RAJO; van Waarde A; Elsinga PH; Luurtsema G
    Mol Pharm; 2021 Aug; 18(8):3073-3085. PubMed ID: 34228458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of P-glycoprotein function at the human blood-brain barrier using [
    Mossel P; Arif WM; De Souza GS; Varela LG; van der Weijden CWJ; Boersma HH; Willemsen ATM; Boellaard R; Elsinga PH; Borra RJH; Dierckx RAJO; Lammertsma AA; Bartels AL; Luurtsema G
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3917-3927. PubMed ID: 37552369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic Modeling of [
    García-Varela L; Arif WM; Vállez García D; Kakiuchi T; Ohba H; Harada N; Tago T; Elsinga PH; Tsukada H; Colabufo NA; Dierckx RAJO; van Waarde A; Toyohara J; Boellaard R; Luurtsema G
    Mol Pharm; 2020 Sep; 17(9):3477-3486. PubMed ID: 32787277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-head comparison of (R)-[
    García-Varela L; Vállez García D; Aguiar P; Kakiuchi T; Ohba H; Harada N; Nishiyama S; Tago T; Elsinga PH; Tsukada H; Colabufo NA; Dierckx RAJO; van Waarde A; Toyohara J; Boellaard R; Luurtsema G
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4307-4317. PubMed ID: 34117508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First clinical assessment of [
    Toyohara J; Sakata M; Ishibashi K; Mossel P; Imai M; Wagatsuma K; Tago T; Imabayashi E; Colabufo NA; Luurtsema G; Ishii K
    Ann Nucl Med; 2021 Nov; 35(11):1240-1252. PubMed ID: 34368924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [
    Garcia-Varela L; Mossel P; Aguiar P; Vazquez-Matias DA; van Waarde A; Willemsen ATM; Bartels AL; Colabufo NA; Dierckx RAJO; Elsinga PH; Luurtsema G
    J Control Release; 2022 Jul; 347():500-507. PubMed ID: 35588934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic Modeling of (
    García-Varela L; García DV; Kakiuchi T; Ohba H; Nishiyama S; Tago T; Elsinga PH; Tsukada H; Colabufo NA; Dierckx RAJO; van Waarde A; Toyohara J; Boellaard R; Luurtsema G
    Mol Pharm; 2021 Jan; 18(1):416-428. PubMed ID: 33315404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of [
    Savolainen H; Windhorst AD; Elsinga PH; Cantore M; Colabufo NA; Willemsen AT; Luurtsema G
    J Cereb Blood Flow Metab; 2017 Apr; 37(4):1286-1298. PubMed ID: 27354093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MC225, a Novel Probe for P-glycoprotein PET Imaging at the Blood-brain Barrier: In Vitro Cardiovascular Safety Evaluation.
    Fusi F; Durante M; Gorelli B; Perrone MG; Colabufo NA; Saponara S
    J Cardiovasc Pharmacol; 2017 Dec; 70(6):405-410. PubMed ID: 28877068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of cyclosporine inhibition of P-glycoprotein activity using 11C-verapamil in the brain: studies of healthy humans.
    Muzi M; Mankoff DA; Link JM; Shoner S; Collier AC; Sasongko L; Unadkat JD
    J Nucl Med; 2009 Aug; 50(8):1267-75. PubMed ID: 19617341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parametric Imaging of P-Glycoprotein Function at the Blood-Brain Barrier Using k
    Breuil L; El Biali M; Vodovar D; Marie S; Auvity S; Bauer M; Goutal S; Rodrigo S; Langer O; Tournier N
    Mol Imaging Biol; 2023 Dec; 25(6):1135-1141. PubMed ID: 37801196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging the Impact of the P-Glycoprotein (ABCB1) Function on the Brain Kinetics of Metoclopramide.
    Pottier G; Marie S; Goutal S; Auvity S; Peyronneau MA; Stute S; Boisgard R; Dollé F; Buvat I; Caillé F; Tournier N
    J Nucl Med; 2016 Feb; 57(2):309-14. PubMed ID: 26585058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain.
    Elsinga PH; Hendrikse NH; Bart J; van Waarde A; Vaalburg W
    Mol Imaging Biol; 2005; 7(1):37-44. PubMed ID: 15912274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of P-glycoprotein function at the blood-brain barrier using [
    Mossel P; Garcia Varela L; Arif WM; van der Weijden CWJ; Boersma HH; Willemsen ATM; Boellaard R; Elsinga PH; Borra RJH; Colabufo NA; Toyohara J; de Deyn PP; Dierckx RAJO; Lammertsma AA; Bartels AL; Luurtsema G
    Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):4105-4106. PubMed ID: 34089347
    [No Abstract]   [Full Text] [Related]  

  • 16. Importance of P-gp PET Imaging in Pharmacology.
    Toyohara J
    Curr Pharm Des; 2016; 22(38):5830-5836. PubMed ID: 27494065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Preclinical Evaluation of Three Novel Fluorine-18 Labeled Radiopharmaceuticals for P-Glycoprotein PET Imaging at the Blood-Brain Barrier.
    Savolainen H; Cantore M; Colabufo NA; Elsinga PH; Windhorst AD; Luurtsema G
    Mol Pharm; 2015 Jul; 12(7):2265-75. PubMed ID: 26043236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [(11)C]-N-desmethyl-loperamide PET study in nonhuman primates.
    Damont A; Goutal S; Auvity S; Valette H; Kuhnast B; Saba W; Tournier N
    Eur J Pharm Sci; 2016 Aug; 91():98-104. PubMed ID: 27283486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of [11C]verapamil measured with PET.
    Bart J; Willemsen AT; Groen HJ; van der Graaf WT; Wegman TD; Vaalburg W; de Vries EG; Hendrikse NH
    Neuroimage; 2003 Nov; 20(3):1775-82. PubMed ID: 14642487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ABCB1 and ABCG2 at the Mouse Blood-Brain Barrier with Marketed Drugs To Improve Brain Delivery of the Model ABCB1/ABCG2 Substrate [
    Traxl A; Mairinger S; Filip T; Sauberer M; Stanek J; Poschner S; Jäger W; Zoufal V; Novarino G; Tournier N; Bauer M; Wanek T; Langer O
    Mol Pharm; 2019 Mar; 16(3):1282-1293. PubMed ID: 30694684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.